New research findings suggest that most vulnerable patients across Africa are at risk of receiving sub-optimal malaria treatment

(Burness) A large proportion of malaria patients in endemic countries in Africa are likely to receive doses of malaria medicine that are too low to offer effective treatment, according to new research presented at the MIM Conference taking place in Dakar this week. Researchers found that an estimated 21.3 million people -- or 24 percent of all confirmed malaria cases--were at risk of being prescribed inadequate doses of artemisinin-based combination therapy (ACTs), the frontline treatment against Plasmodium falciparum malaria.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news